The clinical spectrum of heterozygous POLG2 mutations comprise cerebellar ataxia, seizures, peripheral neuropathy, CPEO, and other movement disorders (tremor, parkinsonism) in adulthood-onset and metabolic abnormalities and seizures in childhood-onset cases [43, 51]. The gene discussed is POLG2; the disease is Parkinsonism.